Crossing barriers: the burden of inflammatory bowel disease across Western Europe
Kumar, Aditi Yassin, Nuha Marley, Alexandra Bellato, Vittoria Foppa, Caterina Pellino, Gianluca Myrelid, Pär Millan, Monica Gros, Beatriz Avellaneda, Nicolas
Kumar, Aditi
Yassin, Nuha
Marley, Alexandra
Bellato, Vittoria
Foppa, Caterina
Pellino, Gianluca
Myrelid, Pär
Millan, Monica
Gros, Beatriz
Avellaneda, Nicolas
Abstract
An estimated 2.5-3 million individuals (0.4%) in Europe are affected by inflammatory bowel disease (IBD). Whilst incidence rates for IBD are stabilising across Europe, the prevalence is rising and subsequently resulting in a significant cost to the healthcare system of an estimated 4.6-5.6 billion euros per year. Hospitalisation and surgical resection rates are generally on a downward trend, which is contrary to the rising cost of novel medication. This signifies a large part of healthcare cost and burden. Despite publicly funded healthcare systems in most European countries, there is still wide variation in how patients receive and/or pay for biologic medication. This review will provide an overview and discuss the different healthcare systems within Western Europe and the barriers that affect overall management of a changing IBD landscape, including differences to hospitalisation and surgical rates, access to medication and clinical trial participation and recruitment. This review will also discuss the importance of standardising IBD management to attain high-quality care for all patients with IBD.
MIDER Authors
Citations
Altmetric:
Date
2023-12-22
Type
Article
Subject
Gastroenterology
Collections
Citation
Kumar A, Yassin N, Marley A, Bellato V, Foppa C, Pellino G, Myrelid P, Millan M, Gros B, Avellaneda N, Catalan-Serra I, El-Hussuna A, Cunha Neves JA, Roseira J, Cunha MF, Verstockt B, Bettenworth D, Mege D, Brookes MJ. Crossing barriers: the burden of inflammatory bowel disease across Western Europe. Therap Adv Gastroenterol. 2023 Dec 22;16:17562848231218615. doi: 10.1177/17562848231218615.
Journal / Source Title
Therapeutic Advances in Gastroenterology
DOI
10.1177/17562848231218615
PMID
38144422
Publisher
SAGE Publications
Publisher’s URL
https://journals.sagepub.com/home/tag